Tuesday, February 24, 2015
Celldex brain cancer immunotherapy is ‘breakthrough’
Celldex brain cancer immunotherapy is ‘breakthrough’ Feb 23, 2015 Shares of Celldex Therapeutics jumped nearly 17% on the news that the US Food and Drug Administration has granted breakthrough therapy designation to its brain cancer immunotherapy Rintega. The designation for Rintega (rindopepimut) has been granted by the agency for patients [...] Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment